Superior complete response rate and progression-free survival after autologous stem-cell transplantation (ASCT) incorporating velcade-thalidomide-dexamethasone (VTD)compared to thalidomide-dexametha-sone (TD) in newly diagnosed multiple myelona

CAVO M;PANTANI L;PATRIARCA F;PETRUCCI M. T;TACCHETTI P;GALLI L;DI RAIMONDO, FRANCESCO;CRIPPA C;BRINGHEN S;MONTEFUSCO V;NARNI F;OFFIDANI M;SPADANO T;OLIVERO B;PESCOSTA N;CARAVITA T;CELLINI C;LEDDA A;FALCONE A;AGOSTINI P;CAVRARO M;MASINI L;NOZZOLI C;BALLANTI S;DERUDAS D;DE STEFANO V;PISANI F;CALIFANO C;CALLEA V;CATANIA G;NOZZA A;PALMIERI S;PECCATORI J;BARALDI A;FATTORI PP;PASINI S;MUSTO P;GRASSO M;BALLERINI F;CANGIALOSI C;CATALANO L;MORANDI S;RONCONI S;BACCARANI M.

2009-01-01